HIGHLIGHTS
- who: Lirui Tang from the Columbia University Irving Medical Center, United States have published the research work: Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma, in the Journal: (JOURNAL)
- what: This study was approved by the Medical Ethics Committee of the Beijing Cancer Hospital and Institute and was conducted according to the Declaration of Helsinki Principles.
SUMMARY
Primary mucosal melanoma (MM), which accounts for approximately 1.3% of all melanomas occurring in Caucasian populations, is a rare but fatal malignancy arising from melanocytes. Subsequent to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.